Gold Pulls Back As Near Term Traders Book Profits
Gold prices continued to march up undeterred overnight as a 1.5% gain brought the metal to a fresh three-week high. That momentum softened however after the U.S.
Author Archive - Market Exclusive
Apple Inc. (AAPL) AI Siri Saves Child By Calling Emergency Services
The child’s mother Stacey Gleeson saw her baby turning blue through a baby monitor and as she rushed into the room to save the child, she dropped her handset.
Trevena Inc (TRVN) Just Got Its Billion Dollar Pain Management Bid Underway
Trevena Inc (NASDAQ:TRVN) just kicked off a two concurrent phase III pivotals in its lead pain management candidate, Oliceridine.
Pfizer Inc. (PFE) Troxyca ER Receives FDA Panel Approval
Pfizer Inc. (NYSE:PFE) painkiller drug Troxyca ER has received the backing of an FDA advisory panel for marketing approval.
ADTRAN, Inc. (ADTN) Leaps Over The Competition With First Open vCPE
ADTRAN, Inc. (NASDAQ:ADTN) is celebrating a milestone after it recently demonstrated the first open and multi-vendor vCPE (virtual Customer Premise Equipment).
GlaxoSmithKline PLC (ADR) (GSK) To Accelerate Filing For COPD Combo Treatment
GlaxoSmithKline plc (ADR) (NYSE:GSK) has come up with a plan that will enable it to file for approval of its triple-combo drug for COPD patients sooner than earlier anticipated...
Gold Prices Climb To Three-Week Highs After Markets Discount Early Rate Hike
SPDR Gold Trust (ETF) (NYSEARCA:GLD) and corresponding gold prices rallied for another session today as markets became less convinced of the likelihood of a June rate hike in...
Ariad Pharmaceuticals, Inc. (ARIA) To Seek Regulatory Clearance For Brigatinib In 3Q
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has said that it will file a new drug application (NDA) for its pipeline candidate brigatinib in 3Q2016.
Johnson & Johnson (JNJ) And GlaxoSmithKline PLC (ADR) (GSK) Rheumatoid Arthritis Drug Meets Targets In Large Phase 3 Study
A drug being developed jointly by Johnson & Johnson (NYSE:JNJ) and GlaxoSmithKline plc (ADR) (NYSE:GSK) met endpoints in a large Phase 3 study that enrolled 1,670 patients...
GlaxoSmithKline PLC (ADR) (GSK) Poised To Overtake Sanofi SA (ADR) (SNY) In This $1.8 Billion Market
GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales.
Advanced Accelerator Application SA (ADR) (AAAP) Expands Pipeline With NeoBOMB1
Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP) has announced the expansion of its theranostic pipeline with the addition of NeoBOMB1, which it describes as a novel GRPR...
Nokia Corp (ADR) (NOK), Ericsson Bid With Rivada Mercury To Create Broadband Network
The three companies are bidding for a partnership position with FirstNet.
Alphabet Inc (GOOGL) Android Marshmallow Reaches 10% Adoption
The report indicates that it is the first time that the OS has reached double digits in percentage.
Vodafone Group Plc (ADR) (VOD) In Merger Negotiations With Sky
The rumors of merger talks were confirmed following the company’s shares being placed on hold on the New Zealand Stock Exchange on Wednesday.
Tesla Motors Inc (TSLA) Musk Denies Claims About Samsung Supplying Batteries For Model 3
Musk was responding to earlier claims and publications suggesting that Samsung SDI and Tesla are negotiating a deal where Samsung will supply the electric automobile maker with...
All You Need To Know About Array Biopharma Inc (ARRY)’s Upcoming NDA Submission
Array Biopharma Inc (NASDAQ:ARRY) just reported detailed topline from a recently completed oncology pivotal, and alongside the report, announced it expects to submit a New Drug...
